Aprea Therapeutics Inc (APRE)
3.972
+0.05
(+1.32%)
USD |
NASDAQ |
Nov 04, 16:00
Aprea Therapeutics Enterprise Value: -7.121M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | -7.121M |
| November 01, 2024 | -7.402M |
| October 31, 2024 | -7.456M |
| October 30, 2024 | -6.913M |
| October 29, 2024 | -5.609M |
| October 28, 2024 | -5.446M |
| October 25, 2024 | -6.532M |
| October 24, 2024 | -7.510M |
| October 23, 2024 | -7.510M |
| October 22, 2024 | -5.989M |
| October 21, 2024 | -5.338M |
| October 18, 2024 | -4.794M |
| October 17, 2024 | -4.523M |
| October 16, 2024 | -9.683M |
| October 15, 2024 | -12.13M |
| October 14, 2024 | -14.79M |
| October 11, 2024 | -14.57M |
| October 10, 2024 | -14.90M |
| October 09, 2024 | -14.79M |
| October 08, 2024 | -14.57M |
| October 07, 2024 | -14.46M |
| October 04, 2024 | -14.57M |
| October 03, 2024 | -14.46M |
| October 02, 2024 | -14.00M |
| October 01, 2024 | -14.57M |
| Date | Value |
|---|---|
| September 30, 2024 | -13.76M |
| September 27, 2024 | -13.76M |
| September 26, 2024 | -12.83M |
| September 25, 2024 | -13.11M |
| September 24, 2024 | -12.51M |
| September 23, 2024 | -12.07M |
| September 20, 2024 | -11.69M |
| September 19, 2024 | -12.83M |
| September 18, 2024 | -13.16M |
| September 17, 2024 | -12.34M |
| September 16, 2024 | -11.94M |
| September 13, 2024 | -11.58M |
| September 12, 2024 | -10.12M |
| September 11, 2024 | -11.20M |
| September 10, 2024 | -10.88M |
| September 09, 2024 | -10.77M |
| September 06, 2024 | -10.50M |
| September 05, 2024 | -10.47M |
| September 04, 2024 | -9.683M |
| September 03, 2024 | -10.61M |
| August 30, 2024 | -10.07M |
| August 29, 2024 | -10.61M |
| August 28, 2024 | -9.683M |
| August 27, 2024 | -9.592M |
| August 26, 2024 | -9.411M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-33.92M
Minimum
May 18 2022
987.30M
Maximum
Dec 27 2019
123.22M
Average
0.4512M
Median
Enterprise Value Benchmarks
| Aethlon Medical Inc | -3.514M |
| Brainstorm Cell Therapeutics Inc | 6.099M |
| NovaBay Pharmaceuticals Inc | 3.645M |
| Palatin Technologies Inc | 13.74M |
| iBio Inc | 9.837M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.470M |
| Total Expenses (Quarterly) | 3.847M |
| EPS Diluted (Quarterly) | -0.58 |
| Earnings Yield | -76.29% |